Apr 2022 Articles

Articles
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
Bergmark BA, Marston NA, Bramson CR, et al.
Journal:
Circulation

First published: April 3, 2022 DOI: 10.1161/CIRCULATIONAHA.122.059266
View
- Share
Articles
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
Nissen SE, Wolski K, Balog C, et al.
Journal:
JAMA

First published: April 3, 2022 DOI: 10.1001/jama.2022.5050
View
- Share
Articles
The Potential Clinical Benefit of Lowering Lipoprotein(a)
Ference BA
Journal:
JAMA

First published: April 3, 2022 DOI: 10.1001/jama.2022.5333
View
- Share
Articles
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
Ostadal P, Steg PG, Poulouin Y, et al.
Journal:
Lancet Diabetes Endocrinol

First published: April 1, 2022 DOI: 10.1016/S2213-8587(22)00043-2
View
- Share

1 2